| Name | Title | Contact Details |
|---|
MAS is at the forefront of Singapores rapidly growing financial industry, creating new policies and initiatives that address the ever-changing landscape. Work at MAS promises not only challenges worthy of your intellectual abilities, but also the personal satisfaction that comes from building one of Asias premier financial hubs. We invite you to take up the challenge and make a difference to Singapores economic and financial development! At MAS, we place a great emphasis on developing a vibrant and conducive work environment that motivates each and every employee to make a meaningful contribution to the organisation. Our people recognize the importance of upholding our values to achieve more together. We believe that it is essential that our people enjoy working here with one another. MAS Functions - To act as the central bank of Singapore, including the conduct of monetary policy, the issuance of currency, the oversight of payment systems and serving as banker to and financial agent of the Government - To conduct integrated supervision of financial services and financial stability surveillance - To manage the official foreign reserves of Singapore - To develop Singapore as an international financial centre
Based in Austin, Texas, TimberTown Specialty Building Products supplies high quality lumber and building materials for a wide variety of residential and commercial projects. Our products range from high-end exotic hardwoods, softwoods and composites; often specially milled for different applications. The types of projects we supply can be as simple as a small residential outdoor cedar deck, to the very complex hardwood siding for a multi-million dollar custom home or a rooftop patio on a downtown high-rise. With such a large and diverse client base, we excel in providing exceptional service for contractors and commercial builders, architects, designers and their clients.
AMB Sports and Entertainment, based in Atlanta, Georgia, is a dynamic organization under the Blank Family of Businesses, led by entrepreneur Arthur Blank. The company manages a diverse portfolio that includes professional sports teams, venues, and retail operations. Key components of AMB Sports and Entertainment include the NFLs Atlanta Falcons, the MLSs Atlanta United FC, and the Atlanta Drive GC, which is set to debut in the Tomorrow Golf League in 2025. The company operates the Mercedes-Benz Stadium, a versatile venue for sports and major events, and The Home Depot Backyard, an outdoor space for community activities. Additionally, it runs the PGA TOUR Superstore, a nationwide golf retail chain. AMBSE Ventures focuses on strategic investments in sports technology and entertainment. The organization is committed to community engagement through various initiatives, including diversity programs and large-scale events. With a dedicated leadership team and a growing workforce, AMB Sports and Entertainment continues to enhance its impact in the sports and entertainment landscape.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.